Cryopreserved ampule of Human Peripheral Blood CD8+ T Cells containing 10 million cells
Do you need a modified version of this cell product, such as different vialing sizes, matched immune cell isolations or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research
Cryopreserved ampule of Human Adipose-Derived Stem Cells (hADSC) containing ≥1 million cells
The PyroCell® MAT System, IL-6 is an all-inclusive kit to conduct the MAT assay. It combines the PyroCell® MAT Kit and the Pelikine compact human IL-6 ELISA kit. It contains 3 vials of cryopreserved, pooled PBMC (pMAT Cells), 3 vials of MAT Culture Medium Supplement, the PeliKine compact human IL-6 kit and the PeliKine tool set 1 sufficient for 288 test (3 ELISA plate).
PyroCell® Monocyte Activation Test (MAT) Kit qualified for the monocyte activation test including 3 vials pooled PBMC (pMAT cells, 4 donors) as well as 3 vials of Cell Culture Medium Supplement for 3 x 96-well ELISA plates.
The PyroCell® Monocyte Activation Test – Human Serum Kit combines 3 vials of cryopreserved, pooled PBMC (human, pMAT cells), and 3 vials of cryopreserved Human Serum Supplement, for 288 tests (3x 96-well microtiter plates).
The PyroCell® Monocyte Activation Test – Human Serum System (PyroCell® MAT HS System) is an all-inclusive kit to conduct the Monocyte Activation Test. It contains 3 vials of cryopreserved, pooled PBMC (human, pMAT Cells), 3 vials Human Serum Supplement, the PeliKine compact human IL-6 kit and the PeliKine tool set, for 288 test (3x 96-well microtiter plates).
-
Natural Killer Cells InfographicNatural Killer cells have an innate ability to recognize and destroy non-self cells.
-
3D Natural Killer Cell-mediated Cytotoxicity AssayLonza White Paper
-
3D Natural Killer (NK) Cell-mediated Cytotoxicity (CMC) Assay
-
Natural Killer (NK) Cell Expansion, Activation and Cytotoxicity AssayProtocol instructions
-
Therapeutic Approaches to Enhance Natural Killer Cell Cytotoxicity: The Force AwakensPoster published by Nature Reviews Drug Discovery, sponsored by Lonza. Natural killer (NK) cells are emerging as attractive candidates for new immunotherapeutic approaches. The poster shows the approaches to NK cell tumor targeting.
-
Transfection Protocol for Human NK Cells - Nucleofector™ I/II/2b Device SeriesInstructions of use for transfection of human natural killer cells with Nucleofector™ 1/2 Devices (incl. 1, 2b, 2N, 2S)
-
An Innovative, Highly Efficient Method for Transfecting Large Quantities of Primary Human T-cellsA strong need exists for improved cancer treatment options. Lonza's approach relies on genetically modified, patient-derived cells like T-cells or natural killer cells which express chimeric antigen receptors (CAR) targeting cancer cells.
-
NK Cell Assay using 3D Bioprinted Tumor ModelsThis white paper describes an ex vivo assay for NK cell killing activity in a 3D bioprinted cervical cancer tumor model.
-
TechSheet - Poietics™ Human Immune System CellsTechnical Product Information Sheet
-
References - X-Vivo™Overview of relevant references